A detailed history of Bar Harbor Wealth Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Bar Harbor Wealth Management holds 116,668 shares of NVO stock, worth $9.92 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
116,668
Previous 213,198 45.28%
Holding current value
$9.92 Million
Previous $30.4 Million 54.35%
% of portfolio
0.89%
Previous 2.06%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$119.07 - $145.42 $11.5 Million - $14 Million
-96,530 Reduced 45.28%
116,668 $13.9 Million
Q2 2024

Jul 17, 2024

SELL
$122.71 - $146.91 $3.04 Million - $3.64 Million
-24,750 Reduced 10.4%
213,198 $30.4 Million
Q1 2024

Apr 23, 2024

SELL
$102.11 - $135.92 $1.7 Million - $2.26 Million
-16,620 Reduced 6.53%
237,948 $30.6 Million
Q4 2023

Jan 17, 2024

SELL
$87.78 - $105.45 $3.57 Million - $4.29 Million
-40,694 Reduced 13.78%
254,568 $26.3 Million
Q3 2023

Nov 28, 2023

BUY
$90.94 - $199.54 $13.3 Million - $29.1 Million
146,073 Added 97.91%
295,262 $26.9 Million
Q2 2023

Aug 09, 2023

SELL
$155.98 - $172.65 $1.23 Million - $1.36 Million
-7,885 Reduced 5.02%
149,189 $24.1 Million
Q1 2023

Apr 24, 2023

SELL
$132.34 - $159.14 $398,475 - $479,170
-3,011 Reduced 1.88%
157,074 $25 Million
Q4 2022

Jun 09, 2023

BUY
$102.55 - $135.33 $308,778 - $407,478
3,011 Added 1.92%
160,085 $21.7 Million
Q4 2022

Jan 19, 2023

SELL
$102.55 - $135.33 $87,987 - $116,113
-858 Reduced 0.53%
160,085 $21.7 Million
Q3 2022

Oct 24, 2022

SELL
$95.28 - $116.93 $239,152 - $293,494
-2,510 Reduced 1.54%
160,943 $16 Million
Q2 2022

Aug 12, 2022

BUY
$103.24 - $121.81 $11.8 Million - $13.9 Million
113,871 Added 229.66%
163,453 $18.2 Million
Q1 2022

Apr 14, 2022

SELL
$93.1 - $112.54 $492,592 - $595,449
-5,291 Reduced 9.64%
49,582 $5.51 Million
Q4 2021

Jan 28, 2022

SELL
$95.88 - $117.08 $360,892 - $440,689
-3,764 Reduced 6.42%
54,873 $6.15 Million
Q3 2021

Nov 15, 2021

SELL
$84.42 - $106.62 $66,016 - $83,376
-782 Reduced 1.32%
58,637 $5.63 Million
Q2 2021

Aug 11, 2021

SELL
$67.66 - $84.76 $126,727 - $158,755
-1,873 Reduced 3.06%
59,419 $4.98 Million
Q1 2021

May 06, 2021

SELL
$67.06 - $75.82 $8,181 - $9,250
-122 Reduced 0.2%
61,292 $4.13 Million
Q4 2020

Feb 09, 2021

BUY
$63.89 - $73.8 $594,943 - $687,225
9,312 Added 17.87%
61,414 $4.29 Million
Q3 2020

Nov 02, 2020

BUY
$63.69 - $70.22 $628,238 - $692,650
9,864 Added 23.35%
52,102 $3.62 Million
Q2 2020

Aug 04, 2020

BUY
$58.54 - $67.94 $2.19 Million - $2.54 Million
37,448 Added 781.8%
42,238 $2.77 Million
Q1 2020

May 14, 2020

BUY
$49.46 - $64.78 $236,913 - $310,296
4,790 New
4,790 $288,000
Q1 2018

Apr 06, 2018

SELL
$48.49 - $58.14 $182,128 - $218,373
-3,756 Closed
0 $0
Q4 2017

Jan 17, 2018

BUY
$47.53 - $53.73 $178,522 - $201,809
3,756
3,756 $201,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bar Harbor Wealth Management Portfolio

Follow Bar Harbor Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bar Harbor Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Bar Harbor Wealth Management with notifications on news.